Table 3: Treatment(s) prescribed by providers at the patient’s initial visit.
Topical steroid | 31 (78%) |
Topical anti-fungal | 8 (20%) |
No treatment | 6 (13%) |
Lidocaine gel | 4 (10%) |
Oral anti-fungal | 3 (8%) |
Hydroxyzine | 3 (8%) |
Topical estrogen | 1 (3%) |
Metronidazole | 1 (3%) |
Vaginal moisturizer | 1 (3%) |
All values are listed as n (%). Patients can be included in more than one category.